Sandoz Settles States' Generics Price-Fixing Cases For $450M

By Matthew Perlman · August 3, 2026, 6:25 PM EDT

Sandoz reached a settlement with a coalition of state enforcers on Monday, agreeing to pay $450 million to end claims against it in several cases targeting alleged price-fixing in the generic...

To view the full article, register now.

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

2:16-md-02724

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016


Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

3:16-cv-02056

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

December 15, 2016


Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

3:19-cv-00710

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

May 10, 2019


Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

3:20-cv-00802

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

June 10, 2020


Case Title

Connecticut et al v. Novartis AG et al

Case Number

2:26-cv-00160

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

February 02, 2026